Northera 300 MG capsule 90S
Ended Awarded
- Contract number
- SPE2DR26FKJG2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,852
Award facts
- Contract value 100% obligated
- $16,851.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $16,851.70 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Northera 300 mg capsules (90-count units). The contract is structured as a firm fixed-price delivery order with an ultimate completion date of November 21, 2025, and does not utilize a set-aside designation. This award is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency, specifically the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which carries a ceiling value of $499,999,999 and extends through December 31, 2036.
The PPV-G GEN V represents a $30.3 billion acquisition strategy designed to provide the Department of Defense with a comprehensive pharmaceutical supply chain supporting military healthcare facilities worldwide. DMS Pharmaceutical Group's established performance across numerous delivery orders and its extensive product portfolio—spanning branded and generic pharmaceuticals, biologics, vaccines, specialty medications, and medical consumables—demonstrates its critical role as a regional prime vendor contractor within this broader federal medical supply network. The company's SAM registration since 2001 and consistent contract performance with the Defense Logistics Agency Medical Supply Chain division position it as a reliable supplier for recurring pharmaceutical requirements across the military healthcare system.
Quick answers
Who was awarded contract SPE2DR26FKJG2?
SPE2DR26FKJG2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DR26FKJG2 worth?
The government has obligated $16,852 on SPE2DR26FKJG2.
Is contract SPE2DR26FKJG2 an order under another contract?
Yes. SPE2DR26FKJG2 is a delivery order under SPE2DR25D9105, an indefinite delivery contract.
Was contract SPE2DR26FKJG2 competed?
The extent of competition for SPE2DR26FKJG2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award